Endologix (NASDAQ: ELGX) and MPM portfolio company TriVascular Technologies merged, leaving Endologix as the surviving corporation.  TriVascular developed the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved EVAR system.  Ovation significantly advances minimally invasive treatment of abdominal aortic aneurysms, utilizing a novel, polymer-based sealing mechanism.  As a result of the merger Endologix is the largest independent company in EVAR.

endologix.com